Exercise-induced hyperinsulinism

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:165991OMIM:610021E16.1
Who is this for?
Show terms as
10Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Exercise-induced hyperinsulinism (EIHI), also known as exercise-induced hyperinsulinemic hypoglycemia, is a rare genetic disorder characterized by inappropriate and excessive insulin secretion triggered by strenuous physical exercise. This condition is caused by activating mutations in the SLC16A1 gene (also known as MCT1), which encodes monocarboxylate transporter 1. Normally, this transporter is not expressed in pancreatic beta cells, but gain-of-function mutations lead to its ectopic expression, allowing pyruvate and lactate generated during exercise to enter beta cells and stimulate insulin release. This results in episodes of hypoglycemia (dangerously low blood sugar) during or shortly after vigorous anaerobic exercise. The primary body system affected is the endocrine/metabolic system, specifically the insulin-regulating function of the pancreas. Key clinical features include recurrent hypoglycemic episodes provoked by exercise, which can manifest as confusion, dizziness, weakness, seizures, and loss of consciousness. Importantly, patients typically do not experience hypoglycemia during fasting or in the absence of exercise, which distinguishes this condition from other forms of congenital hyperinsulinism. Symptoms often become apparent in childhood when children begin engaging in more vigorous physical activities. Management of exercise-induced hyperinsulinism focuses on preventing hypoglycemic episodes. Patients are advised to avoid intense anaerobic exercise or to consume carbohydrate-rich snacks before and during physical activity. Diazoxide, a medication that suppresses insulin secretion, may be used in some cases, though its effectiveness can vary. Unlike some other forms of congenital hyperinsulinism, surgical intervention (pancreatectomy) is generally not required. With appropriate dietary management and activity modification, most patients can lead relatively normal lives, though careful monitoring remains important.

Also known as:

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

3 events
Sep 2025Can Gut Bacteria Predict Who Benefits Most From Exercise? A Gut Supplement to Help Exercise Non-Responders

Texas Christian University — NA

TrialNOT YET RECRUITING
Feb 2022mTOR as Mediator of Insulin Sensitivity Study

University of Copenhagen — NA

TrialRECRUITING
Sep 2009The TRIABETES - ARMMS-T2D Study: A Randomized Trial to Compare Surgical and Medical Treatments for Type 2 Diabetes

University of Pittsburgh — NA

TrialACTIVE NOT RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Exercise-induced hyperinsulinism.

View clinical trials →

No actively recruiting trials found for Exercise-induced hyperinsulinism at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Exercise-induced hyperinsulinism community →

Specialists

10 foundView all specialists →
JP
Jørgen FP Wojtaszewski, Professor
Specialist
PI on 1 active trial
AM
Anita P Courcoulas, MD, MPH
PITTSBURGH, PA
Specialist
PI on 1 active trial
RP
Regina Grazuleviciene, prof.
Specialist
PI on 1 active trial
BP
Bret H Goodpaster, Ph.D.
Specialist
PI on 1 active trial
SP
Sudip Bajpeyi, PhD.
Specialist
PI on 1 active trial
MP
Mary P. Miles, PhD
Specialist
PI on 1 active trial
RP
Robert Ross, PhD
Specialist
PI on 1 active trial
PP
Patrick Schrauwen, Ph.D.
Specialist
PI on 1 active trial
LM
Lena Bilet, MSc.
Specialist
PI on 1 active trial
KJ
Khaled Junaidi
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Exercise-induced hyperinsulinism.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Exercise-induced hyperinsulinismForum →

No community posts yet. Be the first to share your experience with Exercise-induced hyperinsulinism.

Start the conversation →

Latest news about Exercise-induced hyperinsulinism

Disease timeline:

New recruiting trial: Ambient Air and Noise Effect on Cardiovascular Health Risk and Lifestyle Intervention to Attenuate It (METSGREEN)

A new clinical trial is recruiting patients for Exercise-induced hyperinsulinism

New recruiting trial: mTOR as Mediator of Insulin Sensitivity Study

A new clinical trial is recruiting patients for Exercise-induced hyperinsulinism

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Exercise-induced hyperinsulinism

What is Exercise-induced hyperinsulinism?

Exercise-induced hyperinsulinism (EIHI), also known as exercise-induced hyperinsulinemic hypoglycemia, is a rare genetic disorder characterized by inappropriate and excessive insulin secretion triggered by strenuous physical exercise. This condition is caused by activating mutations in the SLC16A1 gene (also known as MCT1), which encodes monocarboxylate transporter 1. Normally, this transporter is not expressed in pancreatic beta cells, but gain-of-function mutations lead to its ectopic expression, allowing pyruvate and lactate generated during exercise to enter beta cells and stimulate insuli

How is Exercise-induced hyperinsulinism inherited?

Exercise-induced hyperinsulinism follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Exercise-induced hyperinsulinism typically begin?

Typical onset of Exercise-induced hyperinsulinism is childhood. Age of onset can vary across affected individuals.

Which specialists treat Exercise-induced hyperinsulinism?

10 specialists and care centers treating Exercise-induced hyperinsulinism are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.